.webp)
By Chris Hiltz
Walk into almost any aesthetic industry trade show and you will see the same scene: rows of glowing, sleek laser towers, energetic sales reps promising six-figure monthly returns, and brochures boasting clinical results that practically sell themselves.
For a plastic surgery practice opening a non-surgical aesthetic wing, or a medspa founder establishing their brand, the urge to purchase a marquee laser system immediately is intense. A high-tech device feels like an official stamp of legitimacy. It signals to patients that your clinic offers cutting-edge medical care.
However, from a financial and operational standpoint, purchasing a high-cost device out of the gate is one of the most common missteps we see at Maven Financial Partners.
Before committing to a five-year loan payment that sits on your financial statements as a liability to be paid month after month, there is a fundamental rule every practice leader should internalize.
When practice owners ask how to launch their non-surgical aesthetic service line, Maven Financial Consultant Katrina Whitehair offers straightforward advice:
"Any spa or plastics practice starting out, that is what I recommend: start with your hands. Injectables, microneedling, facials. Once you have some recurring revenue and traction, then invest in a device—not right out of the gate. Understand the competitive landscape and what the team can sell that fits your practice before buying a device."
There is sound business logic behind this approach.
Hands-on treatments—neurotoxins, dermal fillers, chemical peels, and manual microneedling—carry minimal upfront capital expenditure.
You are investing in consumable inventory and skilled labor rather than a depreciating $150,000 asset financed at prevailing interest rates.
Starting with manual treatments builds an active patient roster and provides immediate gross margin. It creates cash flow stability, which gives your practice breathing room.
If an injector has a slower week, your fixed monthly debt is not bleeding your cash reserves dry while you ramp up marketing.
Rushing into a laser purchase often means buying what a device manufacturer was best at selling you, rather than what your actual patient demographic wants to buy from you.
As Maven Financial Consultant Steve Kehn points out, holding off on hardware initially gives you critical operational data.
Starting with hands-on treatments gives your team the opportunity to see what patients come in, what specific skin concerns they want solved, and what price thresholds they are comfortable with.
A plastic surgery practice might assume their surgical patients want deep, aggressive ablative resurfacing to complement a facelift.
After six months of providing pre-op skincare and injectables, however, you may discover that the majority of your weekly inquiries are actually coming from 30-to-45-year-olds looking for zero-downtime maintenance, sun damage clearance, or melasma management.
When you wait until you have foot traffic, you buy equipment backed by actual patient demand rather than optimistic assumptions.
Another common trap is assuming that acquiring high-end technology will automatically drive bookings.
Practice owners sometimes expect that simply announcing a new laser on Instagram will keep the treatment room booked forty hours a week.
Steve Kehn frequently shares an insight he learned from Founding Partner & Sr. Financial Consultant Christin Trujillo: having the device in your clinic is great, but having the device does not mean it will sell itself.
The real question is: How well will your providers and front-desk team talk about, educate patients on, and sell the treatment?
Every device requires an internal engine:
If your team is not already skilled at converting a neurotoxin patient into a comprehensive treatment plan, dropping a laser into room three will only add stress and fixed debt.
Once your hands-on revenue is consistent, your team has consultation momentum, and your patient base is vocal about their skin health goals, it is time to look at the market.
Rather than investing in niche, aggressive modalities that carry heavy social downtime and narrow demographic appeal, successful practices prioritize versatile workhorses with high patient compliance.
This is why platforms pairing phototherapy and gentle fractional resurfacing frequently top the list of initial purchases.
By addressing both color (reds and browns from sun damage or rosacea) and texture in low-downtime treatment plans, these dual-modality systems can become reliable recurring revenue drivers when appropriately selected for each patient's skin type and concerns.
No matter what device you choose, your first device should fit seamlessly into ongoing memberships and maintenance regimens rather than sitting idle waiting for rare candidates.
Before committing to a lease on any device, run the numbers beyond the sales rep's monthly payment sheet.
Make sure your financial model factors in:
A laser should be an accelerant to an already healthy business, not a gamble intended to save it.
When you build your foundation with your hands, listen to your patient volume, and prepare your staff to educate and package treatments confidently, your first device purchase becomes a dependable profit center rather than an anxious overhead burden.
Are you evaluating a potential device purchase or wondering if your practice is financially ready to expand its service lines?
Schedule a Free Business Assessment with Maven Financial Partners to review your numbers, evaluate device ROI, and build a sustainable roadmap for growth.
Discover where your business stands in the market with Maven Financial Partners' free benchmark audit. Our expert team will analyze your financial performance, providing you with valuable insights and strategies to outperform your competitors. Take advantage of this opportunity to identify strengths, uncover areas for improvement, and gain a competitive edge. Don't miss out on this chance to enhance your business success with our professional guidance.
.webp){kind=spacer}
